The impact of these lineages has been less due to advances in the vaccination system, however, the authorities are constantly alert to the development of the same
Covid-19 continues to have a presence in the country with new variants. (Getty)
Colombia has overcome several peaks of the pandemic caused by COVID-19, a pathology that in 2020 and part of 2021 left millions of Colombians inside their homes. However, despite the fact that the impact of this disease has decreased, concern is now focused on the variant called 'Perro del Infierno', which continues to spread throughout the national territory.
The original name of this variant is BQ.1.x, however, it should be noted that it is a subvariant of the famous Omicron. According to the information presented by the Ministry of Health and the National Institute of Health, the increase in the circulation of the 'Perro del Infierno' has gradually been noted, since its cases continue to have a prudent growth.
Similarly, according to the most recent Genomic Surveillance Report of the National Institute of Health, the circulation of at least two more variants has been noted in Colombia, including BA.5.x and BA.4.x, whose percentage exceeds 30 and 15 percent respectively.
Regarding this monitoring, the National Institute of Health noted:
“INS Genomic Surveillance Report It is observed in the last report that different variants of Ómicron continue to circulate in Colombia, mainly BA.5.x (30.8%) and BA.4.x (15.4%), but these have been displaced by lineages from Ómicron BQ.1.x (34.6%)”.
To this is added the finding of another subvariant, since the XBB lineage already circulates with a presence of more than three percent and is particularly known as 'Nightmare', however, there is an important fact of clarity about this pathology, since this, and the rest of the subvariants, have not had a representative number of affected people that could lead to hospitalizations or deaths.
< p class="paragraph">“INS Genomic Surveillance The circulation of the XBB lineage (3.8%) is also detected. Until now, their circulation in the countries where the new Omicron sublineages were detected have not represented greater hospitalization or lethality”, explained the INS.
According to the COVID-19 data exposed by the Ministry of Health, from November 18 to 24, Colombia registered 14 deaths, 1,106 recovered and 2,112 new cases, leaving a total of 2,333 active symptoms, a number that despite the presence of the lineages mentioned above, have not triggered a noticeable increase in contagion.
Similarly, the vaccination stages throughout the national territory have allowed the impact of COVID-19 to 19 decrease, since the immunological conditions have had a noticeable improvement and reduce the onslaught of the disease, however, the authorities have constantly urged to complete the vaccination schedule.
In Colombia, the vaccination process against the virus is also advancing COVID-19. (Colombia). EFE/Carlos Ortega
The explanation of the World Health Organization
The WHO released, in October, the analysis on the variants and lineages that had the most predominance in the world, since the increase in cases in various areas raised the concern of the authorities and citizenship. According to the Organization, despite the infectious growth of this disease, it is necessary to continue with the investigation and thus be able to expand the data on it.
Regarding the issue, the WHO stated:
“While there are no data on severity or immune escape from human studies, BQ.1 shows a significant growth advantage over other circulating Omicron sublineages in many settings, including Europe and the United States. These additional mutations are likely to have conferred an immunological escape advantage over other circulating Omicron sublineages. and therefore increased risk of reinfection is a possibility that needs further investigation.”